MOSH/MOAH Analysis Without the Usual Struggles With Petra Gerhards
In this Teach Me In 10 episode Petra Gerhards, regional marketing manager for Thermo Fisher Scientific is here to make MOSH/MOAH analysis easier and more successful.
Green Nanotechnology in Cancer Therapy
In this talk Kattesh Katti, describes the application of green nanotechnology in cancer therapy.
Microfluidic Systems for Biomarker Analysis and Cancer Diagnosis
In this talk, Martin Gijs discusses a novel magnetic surface coverage assay and a microfluidic tissue processor with applications in cancer diagnostics.
Detection and Expression Profiling of Tumor Initiating Cells (TIC) Among the Peripherally Circulating Epithelial Tumor Cells from Patients with Breast Cancer
Katharina Pachmann shows that among the peripherally circulating tumor cells a variable fraction is able to express stem cell and adhesion properties and can be grown into tumor spheres, a property ascribed to cells capable of initiating tumors and metastases.
Monitoring Dynamic Interactions of Tumor Cells with Tissue and Immune Cells in a Lab-on-a-Chip
Peter Ertl discusses how for the first time, direct cell-to-cell interactions of tumor cells with bead-activated primary T cells were continuously assessed using an effector cell to target cell ratio of 10:1.
Improvements in Molecular Diagnosis of Pathogens and Diseases
This talk offers a valuable guide to the development of LAMP in molecular detection and determination of target sequences and will present examples with bright field applications of the method from the detection of pathogens to clinical applications for the diagnosis of cancer and other disorders.
DNA Methylation and the Cancer Epigenome Biological and Translations Implications
In this talk, Stephen Baylin, discusses the development of strategies for “epigenetic therapies” for cancer and biomarker development.
The Isolation and Characterization of Brain Metastasis – Competent Breast Cancer CTCs
Dario Marchetti, Professor/Director, Baylor College of Medicine, speaking at CellTech 2013.
Regulation of antibody immunotherapy by fine-tuning FcR interactions
In this talk, Mark Cragg, presents evidence that different mAb's interact with Fc receptors differently in order to achieve their therapeutic activities.